'Kannan s et al' presentation slideshows

Serious adverse events following falsely high glucose measurements resulting from administration of an IGIV product cont

Serious adverse events following falsely high glucose measurements resulting from administration of an IGIV product containing maltose. L. Ross Pierce, M.D. Medical Officer, Clinical Review Branch, Div. of Hematology, FDA.

321 views • 14 slides